1.The distribution of red cell blood group antigens and alloantibodies in surgical transfusion
Journal of Medical and Pharmaceutical Information 2004;0(2):24-26
Objective: Study some red cell blood group antigens and allo-antibodies of blood donors and surgical patients at Viet Duc Hospital order to contribute to safe blood transfusion. Subjects: 122 blood donors were tested antigens of red blood cell: Rh, Kell, Duffy, Lutheran, MNS, Lewis, P... with anti-serum developed by Gamma Company, 393 blood donors were undergone Mill test with anti-Mia, 938 blood donors and 1036 surgical patients were tested by Polybrene method for allo-antibody. Results: frequencies of red blood cell antigens out of ABO system of 122 blood donors were listed in Table 1. Prevalence of Mill antigen in 393 blood donors was 9.9%. Frequencies of allo-antibody were 0% and <1% in 938 blood donors group and surgical patients group, respectively. Among 93 surgical patients had multi-transfusion, frequency of allo-antibody was 4.3%
Antigens
;
Isoantibodies
;
Blood Transfusion
;
surgery
2.Pancreaticoduodenectomy with superior mesenteric artery first-approach combined total meso-pancreas excision for periampullary malignancies:A high-volume single-center experience with short-term outcomes
Thanh Khiem NGUYEN ; Ham Hoi NGUYEN ; Tuan Hiep LUONG ; Kim Khue DANG ; Van Duy LE ; Duc Dung TRAN ; Van Minh DO ; Hong Quang PHAM ; Hoan My PHAM ; Thi Lan TRAN ; Cuong Thinh NGUYEN ; Hong Son TRINH ; Yosuke INOUE
Annals of Hepato-Biliary-Pancreatic Surgery 2024;28(1):59-69
Background:
s/Aims: Pancreaticoduodenectomy (PD) is the only radical treatment for periampullary malignancies. Superior mesenteric artery (SMA) first approach combined with total meso-pancreas (MP) excision was conducted to improve the oncological results.There has not been any previous research of a technique that combines the SMA first approach and total MP excision with a detailed description of the MP macroscopical shape.
Methods:
We prospectively assessed 77 patients with periampullary malignancies between October 2020 and March 2022 (18 months). All patients had undergone PD with SMA first approach combined total MP excision. The perioperative indications, clinical data, intra-operative index, R0 resection rate of postoperative pathological specimens (especially mesopancreatic margin), postoperative complications, and follow-up results were evaluated.
Results:
The median operative time was 289.6 min (178−540 min), the median intraoperative blood loss was 209 mL (30−1,600 mL).Microscopically, there were 19 (24.7%) cases with metastatic MP, and five cases (6.5%) with R1-resection of the MP. The number of lymph nodes (LNs) harvested and metastatic LNs were 27.2 (maximum was 74) and 1.8 (maximum was 16), respectively. Some (46.8%) patients had pancreatic fistula, but mostly in grade A, with 7 patients (9.1%) who required re-operations. Some 18.2% of cases developed postoperative refractory diarrhea. The rate of in-hospital mortality was 1.3%.
Conclusions
The PD with SMA first approach combined TMpE for periampullary malignancies was effective in achieving superior oncological statistics (rate of MP R0-resection and number of total resected LNs) with non-inferior short-term outcomes. It is necessary to evaluate survival outcomes with long-term follow-up.
3.Pancreaticoduodenectomy with superior mesenteric artery first-approach combined total meso-pancreas excision for periampullary malignancies:A high-volume single-center experience with short-term outcomes
Thanh Khiem NGUYEN ; Ham Hoi NGUYEN ; Tuan Hiep LUONG ; Kim Khue DANG ; Van Duy LE ; Duc Dung TRAN ; Van Minh DO ; Hong Quang PHAM ; Hoan My PHAM ; Thi Lan TRAN ; Cuong Thinh NGUYEN ; Hong Son TRINH ; Yosuke INOUE
Annals of Hepato-Biliary-Pancreatic Surgery 2024;28(1):59-69
Background:
s/Aims: Pancreaticoduodenectomy (PD) is the only radical treatment for periampullary malignancies. Superior mesenteric artery (SMA) first approach combined with total meso-pancreas (MP) excision was conducted to improve the oncological results.There has not been any previous research of a technique that combines the SMA first approach and total MP excision with a detailed description of the MP macroscopical shape.
Methods:
We prospectively assessed 77 patients with periampullary malignancies between October 2020 and March 2022 (18 months). All patients had undergone PD with SMA first approach combined total MP excision. The perioperative indications, clinical data, intra-operative index, R0 resection rate of postoperative pathological specimens (especially mesopancreatic margin), postoperative complications, and follow-up results were evaluated.
Results:
The median operative time was 289.6 min (178−540 min), the median intraoperative blood loss was 209 mL (30−1,600 mL).Microscopically, there were 19 (24.7%) cases with metastatic MP, and five cases (6.5%) with R1-resection of the MP. The number of lymph nodes (LNs) harvested and metastatic LNs were 27.2 (maximum was 74) and 1.8 (maximum was 16), respectively. Some (46.8%) patients had pancreatic fistula, but mostly in grade A, with 7 patients (9.1%) who required re-operations. Some 18.2% of cases developed postoperative refractory diarrhea. The rate of in-hospital mortality was 1.3%.
Conclusions
The PD with SMA first approach combined TMpE for periampullary malignancies was effective in achieving superior oncological statistics (rate of MP R0-resection and number of total resected LNs) with non-inferior short-term outcomes. It is necessary to evaluate survival outcomes with long-term follow-up.
4.Pancreaticoduodenectomy with superior mesenteric artery first-approach combined total meso-pancreas excision for periampullary malignancies:A high-volume single-center experience with short-term outcomes
Thanh Khiem NGUYEN ; Ham Hoi NGUYEN ; Tuan Hiep LUONG ; Kim Khue DANG ; Van Duy LE ; Duc Dung TRAN ; Van Minh DO ; Hong Quang PHAM ; Hoan My PHAM ; Thi Lan TRAN ; Cuong Thinh NGUYEN ; Hong Son TRINH ; Yosuke INOUE
Annals of Hepato-Biliary-Pancreatic Surgery 2024;28(1):59-69
Background:
s/Aims: Pancreaticoduodenectomy (PD) is the only radical treatment for periampullary malignancies. Superior mesenteric artery (SMA) first approach combined with total meso-pancreas (MP) excision was conducted to improve the oncological results.There has not been any previous research of a technique that combines the SMA first approach and total MP excision with a detailed description of the MP macroscopical shape.
Methods:
We prospectively assessed 77 patients with periampullary malignancies between October 2020 and March 2022 (18 months). All patients had undergone PD with SMA first approach combined total MP excision. The perioperative indications, clinical data, intra-operative index, R0 resection rate of postoperative pathological specimens (especially mesopancreatic margin), postoperative complications, and follow-up results were evaluated.
Results:
The median operative time was 289.6 min (178−540 min), the median intraoperative blood loss was 209 mL (30−1,600 mL).Microscopically, there were 19 (24.7%) cases with metastatic MP, and five cases (6.5%) with R1-resection of the MP. The number of lymph nodes (LNs) harvested and metastatic LNs were 27.2 (maximum was 74) and 1.8 (maximum was 16), respectively. Some (46.8%) patients had pancreatic fistula, but mostly in grade A, with 7 patients (9.1%) who required re-operations. Some 18.2% of cases developed postoperative refractory diarrhea. The rate of in-hospital mortality was 1.3%.
Conclusions
The PD with SMA first approach combined TMpE for periampullary malignancies was effective in achieving superior oncological statistics (rate of MP R0-resection and number of total resected LNs) with non-inferior short-term outcomes. It is necessary to evaluate survival outcomes with long-term follow-up.
5.Pancreaticoduodenectomy with superior mesenteric artery first-approach combined total meso-pancreas excision for periampullary malignancies:A high-volume single-center experience with short-term outcomes
Thanh Khiem NGUYEN ; Ham Hoi NGUYEN ; Tuan Hiep LUONG ; Kim Khue DANG ; Van Duy LE ; Duc Dung TRAN ; Van Minh DO ; Hong Quang PHAM ; Hoan My PHAM ; Thi Lan TRAN ; Cuong Thinh NGUYEN ; Hong Son TRINH ; Yosuke INOUE
Annals of Hepato-Biliary-Pancreatic Surgery 2024;28(1):59-69
Background:
s/Aims: Pancreaticoduodenectomy (PD) is the only radical treatment for periampullary malignancies. Superior mesenteric artery (SMA) first approach combined with total meso-pancreas (MP) excision was conducted to improve the oncological results.There has not been any previous research of a technique that combines the SMA first approach and total MP excision with a detailed description of the MP macroscopical shape.
Methods:
We prospectively assessed 77 patients with periampullary malignancies between October 2020 and March 2022 (18 months). All patients had undergone PD with SMA first approach combined total MP excision. The perioperative indications, clinical data, intra-operative index, R0 resection rate of postoperative pathological specimens (especially mesopancreatic margin), postoperative complications, and follow-up results were evaluated.
Results:
The median operative time was 289.6 min (178−540 min), the median intraoperative blood loss was 209 mL (30−1,600 mL).Microscopically, there were 19 (24.7%) cases with metastatic MP, and five cases (6.5%) with R1-resection of the MP. The number of lymph nodes (LNs) harvested and metastatic LNs were 27.2 (maximum was 74) and 1.8 (maximum was 16), respectively. Some (46.8%) patients had pancreatic fistula, but mostly in grade A, with 7 patients (9.1%) who required re-operations. Some 18.2% of cases developed postoperative refractory diarrhea. The rate of in-hospital mortality was 1.3%.
Conclusions
The PD with SMA first approach combined TMpE for periampullary malignancies was effective in achieving superior oncological statistics (rate of MP R0-resection and number of total resected LNs) with non-inferior short-term outcomes. It is necessary to evaluate survival outcomes with long-term follow-up.
6.Zika preparedness and response in Viet Nam
Dong T Nguyen ; Hung T Do ; Huy X Le ; Nghia T Le ; Mai Q Vien ; Trieu B Nguyen ; Lan T Phan ; Thuong V Nguyen ; Quang C Luong ; Hung C Phan ; Hai T Diep ; Quang D Pham ; Thinh V Nguyen ; Loan KT Huynh ; Dung CT Nguyen ; Hang TT Pham ; Khanh KH Ly ; Huong NLT Tran ; Phu D Tran ; Tan Q Dang ; Hung Pham ; Long N Vu ; Anthony Mounts ; S Arunmozhi Balajee ; Leisha D Nolen
Western Pacific Surveillance and Response 2018;9(2):1-3
This article describes Viet Nam Ministry of Health’s (VMoH) activities to prepare for and respond to the threat Zika virus (ZIKV), including the adaptation of existing surveillance systems to encompass ZIKV surveillance.